Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous levetiracetam in term neonates with refractory seizures
NL-OMON22555Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by Erasmus MC. Primary endpoints: Safety profile of levetiracetam in neonates, Pharmacokinetics of levetiracetam and 1 more. Started May 2007; status: active, not recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON22555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22555.